Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]
Spectrum Pharmaceuticals Inc (NASDAQ:SPPI)
Recent Posts
UAT Group Strategic Partner Next Casting Receives Patent
Livento Group announces the settlement of the promissory note and an equity investment
Franklin Mining Announced Letter to Shareholders and Investors
New Products, Growth – USMJ.com Memorial Day Sale
M2Bio Sciences Division M2Biome Cardiometabolic Health Launches Website
Popular Post
-
Hollywood Star Cuts Enters Into Acquisition Agreement!
-
FEED EARTH NOW (FEN) ANNOUNCES FOOD WASTE RECYCLING SYSTEM IN CALIFORNIA
-
Allied Enters into Gas Offtake Agreement with Sloan Petroleum to Procure Additional Natural Gas Wells for the Enerhash Bitcoin Mining Project
-
CGAC Completes $894,325 Purchase of 412 Bitcoin Miners, Mining Operations Underway
-
JPMorgan Bringing Back Employees to Work From Office
